Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

AveXis, Inc. (AVXS)

Add AVXS Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/23/2017 3:18:45 PM - Followers: 1 - Board type: Free - Posts Today: 0

AveXis, Inc. 2275 Half Day Road Suite 160 Bannockburn, IL 60015 United States 847-572-8280 AveXis, Inc., a clinical-stage gene therapy company, engages in developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. Its initial product candidate is AVXS-101, a gene therapy product candidate that is in a Phase I clinical trial for the treatment of spinal muscular atrophy Type 1. The company also intends to identify, acquire, develop, and commercialize gene therapy product candidates for the treatment of other rare and life-threatening neurological genetic diseases. It has strategic collaboration and license agreements with Nationwide Children's Hospital; The Research Institute at Nationwide Children's Hospital; REGENXBIO Inc.; and Asklepios Biopharmaceutical, Inc. The company was formerly known as BioLife Cell Bank, Inc. and changed its name to AveXis, Inc. in January 2014. AveXis, Inc. was founded in 2010 and is headquartered in Bannockburn, Illinois.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVXS News: Quarterly Report (10-q) 08/10/2017 04:14:00 PM
AVXS News: Current Report Filing (8-k) 08/10/2017 04:09:06 PM
AVXS News: AveXis Reports Second Quarter 2017 Financial and Operating Results 08/10/2017 04:01:00 PM
AVXS News: Statement of Changes in Beneficial Ownership (4) 08/03/2017 05:03:40 PM
AVXS News: AveXis to Report Second Quarter 2017 Financial and Operating Results 08/03/2017 08:00:00 AM
#3   buying here! Dutchdaan 05/23/17 03:18:45 PM
#1   AVXS bullish 59.44 stocktrademan 11/24/16 12:16:36 PM